Abstract：In the post epidemic period,the biopharmaceutical industry has the opportunity to rise,but it also faces the risk.This paper selects Zhangjiang,Fenglin and the Oriental Beauty Valley,three representative parks in Shanghai,to conduct a case study and explore the risk factors of biopharmaceutical industry clusters.According to the direct relationship between risk factors,the adjacency relationship matrix is established.According to the hierarchical order,the risk factors are layered,and the ISM analytic structure model of cluster risk system is established.The results show the followings.The hierarchical structure of the risk system of biopharmaceutical industry cluster has five levels of characteristics.The bottom elements will directly or indirectly affect the top-level basic elements of technological innovation.Location and system are the important factors.The competitive environment,policy environment and industrial ecological environment are the important external factors.
孙洁. 生物医药产业集群风险的因素诊断与层次分析——基于上海三类园区的案例研究[J]. 中国科技论坛, 2021(12): 62-69.
Sun Jie. Factor Identification and Hierarchical Analysis of Risks in Biopharmaceutical Industry Clusters:Case Study in Shanghai. , 2021(12): 62-69.
[1]GORDON I R,MCCARM P.Industrial clusters:complexes,agglomeration and／or social networks[J].Urban studies,2000,37 (3):513-532. [2]KARAMANAS A G.Complexity identity and the value of knowledge-intensive exchanges[J].Journal of management studies,2003,40 (7):1871-1890. [3]蔡宁,杨闩柱,吴结兵.企业集群风险的研究:一个基于网络的视角[J].中国工业经济,2003 (4):59-64. [4]王聪聪,蔡宁,黄纯.产业集群多层次网络结构对集群风险扩散的影响[J].重庆大学学报 (社会科学版),2013,19 (5):50-55. [5]万幼清,张妮,鲁平俊.产业集群协同创新风险及其形成机理研究[J].管理世界,2015 (2):182-183. [6]朱瑞博.模块化、组织柔性与虚拟再整合产业组织体系[J].产业经济评论,2004 (2):119-133. [7]王国红,梁晓燕等.区域协同创新网络的结构风险研究[J].当代经济管理,2014,36 (7):17-22 [8]刘友金,罗发友.基于焦点企业成长的集群演进机理研究[J].管理世界,2005 (10):159-161. [9]唐丽艳,王然,王国红.基于相继故障的集群协同创新网络风险评价研究[J].科技进步与对策,2015,32 (14):60-64. [10]RITTER T,GEMüNDEN H G.The impact of a company's business strategy on its technological competence,network competence and innovation success[J].Journal of business research,2004,57 (5):548-556. [11]蔡宁,黄纯,孙文文.集群风险自组织理论建构的探索式案例研究[J].中国工业经济,2011 (7):54-65. [12]王卫东.产业集群网络结构风险预警管理系统及其运行模式[J].科技进步与对策,2012,29 (11):58-61. [13]肖玲诺,史建锋,孙玉忠,等.产学研知识创新联盟知识链运作的风险控制机制[J].中国科技论坛,2013 (3):115-120. [14]POWELL W W, WHITE D R.KOPUT W.et al.Network dynamics and field evolution:the growth of inter organizational collaboration in the life sciences[J].The American journal of sociology,2004,110 (4):1132-1205. [15]LALOR F,J FITZPATRICK J,SAGE C,et al.Sustainability in the biopharmaceutical industry:seeking a holistic perspective[J].Biotechnology advances,2019,37 (5):698-707. [16]王飞.生物医药创新网络演化机理研究——以上海张江为例[J].科研管理,2012,33 (2):48-54. [17]叶琴,曾刚.解析型与合成型产业创新网络特征比较——以中国生物医药、节能环保产业为例[J].经济地理,2018,38 (10):142-154. [18]可星,吴倩.新兴产业突破性技术由路径向轨道演化的机制[J].科技管理研究,2019 (13):123-130. [19]VIEIRA M,TANIA P V,ANA P B.A model-based decision support framework for the optimization of production planning in the biopharmaceutical industry[J].Computers & industrial engineering,2019,129 (4):354-367. [20]石璋铭,徐道宣.集聚促进战略性新兴产业创新生态系统发展的实证分析[J].科技进步与对策,2018 (23):92-98. [21]王勇.开放创新范式下医药研发组织模式研究[J].中国科技论坛,2014 (8):11-15. [22]EISENHARDT M,GRAEBNER M E.Theory building from cases:opportunities and challenges[J].Academy of management journal,2007,50 (1):25-32.
2021, 
